CAAS Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

CAAS Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,000	Closed	-$166K	–	434
2024 Q2	$166K	Buy	+4,000	New	+$179K	0.05%	158
2024 Q1	–	Sell	-3,200	Closed	-$164K	–	524
2023 Q4	$164K	Buy	+3,200	New	+$168K	0.02%	358
2022 Q3	–	Sell	-14,900	Closed	-$1.15M	–	850
2022 Q2	$1.15M	Buy	14,900 +11,700	+366%	+$891K	0.06%	349
2022 Q1	$234K	Sell	3,200 -708,300	-100%	-$47.6M	0.01%	442
2021 Q4	$44.4M	Buy	711,500 +600	+0.1%	+$35.2K	1.08%	11
2021 Q3	$42.1M	Hold	710,900	–	–	0.84%	23
2021 Q2	$47.5M	Buy	+710,900	New	+$46.4M	0.8%	18
2021 Q1	–	Sell	-70,000	Closed	-$4.34M	–	1164
2020 Q4	$4.34M	Hold	70,000	–	–	0.04%	347
2020 Q3	$4.22M	Buy	+70,000	New	+$4.21M	0.1%	167

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CAAS Capital Management's BMY Position: Q1 2022 in Review

CAAS Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2022, closing a stake of 547,805 shares — an estimated $36.8M sold.

CAAS Capital Management first reported a position in BMY in Q1 2021 and held it in 3 quarters. The position peaked at $34.2M in Q4 2021. 2,515 funds tracked by Wall St. Rank hold BMY as of Q1 2022.

CAAS Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2022 after selling out during the quarter.
CAAS Capital Management sold 547,805 Bristol-Myers Squibb shares in Q1 2022, an estimated $36.8M.
CAAS Capital Management first reported a position in Bristol-Myers Squibb in Q1 2021 and held it in 3 quarters.
CAAS Capital Management's Bristol-Myers Squibb position peaked at $34.2M in Q4 2021.
2,515 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.

Based on CAAS Capital Management's 13F filing for Q1 2022, filed 13 May 2022.